Brief: Gabather: Positive Relim Results From First Dose Level In Phase 1 Study With Gt-002

Gabather AB

26/08/2020 07:20

Aug 26 (Reuters) - Gabather AB  GABAT.ST :
    * REPORTS POSITIVE PRELIMINARY RESULTS FROM FIRST DOSE LEVEL IN PHASE 1 STUDY WITH GT-002
    * PRELIMINARY DATA SHOW THAT TREATMENT IS TOLEREATED WELL AND NO SIDE EFFECTS HAVE BEEN
REPORTED

Source text for Eikon:  ID:nWkr3wxqGb 
Further company coverage:  GABAT.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))